1 NAME OF THE MEDICINAL PRODUCT
COVISHIELD™
ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant)
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
One dose (0.5 ml) contains:
ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) 5 × 1010 virus particles (vp)
*Recombinant, replication-deficient chimpanzee adenovirus vector encoding the SARS-CoV-2 Spike (S) glycoprotein. Produced in genetically modified human embryonic kidney (HEK) 293 cells
This product contains genetically modified organisms (GMOs).
For the full list of excipients, see section 6.1.
Both COVISHIELD™ (manufactured by Serum Institute of India Pvt Ltd) and COVID-19 Vaccine AstraZeneca (manufactured by AstraZeneca) are ChAdOx1 nCoV- 19 Corona Virus Vaccines (Recombinant).
